Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.59 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.59 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.54 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.54 |
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1249555 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL11914215 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL7995370 | 0.83 | SMN1; SMN2 (0.62) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL7995367 | 0.83 | SMN1; SMN2 (0.62) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL13058940 | 0.80 | CHRNB2 (0.55) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL9826625 | 0.80 | CHRNB2 (0.55) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL1020001 | 0.77 | SMN1; SMN2 (0.64) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL7995849 | 0.77 | CHRNA1 (0.67) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL7993948 | 0.77 | SMN1; SMN2 (0.64) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 | |
| SCHEMBL6624321 | 0.77 | SMN1; SMN2 (1.00) | SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2281812-B1 | NITROGENOUS HETEROCYCLIC COMPOUND WITH INSECTICIDAL ACTIVITY AND ITS PREPARATION AND USE | UNIV EAST CHINA SCIENCE & TECH (CN) | 2014-01-22 | — | — | EP | disclosed |
| US-8232407-B2 | Nitrogenous heterocyclic compounds with insecticidal activity, and the preparation and use thereof | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2012-07-31 | — | — | US | disclosed |
| EP-2281812-A1 | NITROGENOUS HETEROCYCLIC COMPOUND WITH INSECTICIDAL ACTIVITY AND ITS PREPARATION AND USE | East China University of Science and Technology (CN) | 2011-02-09 | — | — | EP | disclosed |
| US-20100298346-A1 | NITROGENOUS HETEROCYCLIC COMPOUNDS WITH INSECTICIDAL ACTIVITY, AND THE PREPARATION AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298346-A1 | NITROGENOUS HETEROCYCLIC COMPOUNDS WITH INSECTICIDAL ACTIVITY, AND THE PREPARATION AND USE THEREOF | NIT2, NOS2, NOS3 | SMN1; SMN2 3997/4885CHRNA1 769/4885CHRNA7 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.